Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Application save search
Radware Provides 360-Degree Cloud Application and Network Security for a Latin American Judiciary
Published: 2023-12-01 (Crawled : 18:00) - globenewswire.com
RDWR | $15.54 1.9% -1.35% 270K
|
Electronic Technology
|
| O: 1.08%
H: 0.0%
C: 0.0%
security cloud network application
Intelligent Living Application Group Inc. Announces First Half 2023 Unaudited Financial Results
Published: 2023-12-01 (Crawled : 08:00) - prnewswire.com
ILAG | $0.7477 3.62% -0.36% 29K
|
|
| O: -2.16%
H: 0.0%
C: 0.0%
group application financial results living
Biora Therapeutics Announces FDA Clearance of IND Application for Drug/Device Combination BT-600 Targeting Treatment of Ulcerative Colitis
Published: 2023-11-30 (Crawled : 00:00) - biospace.com/
BIOR | $1.35 8.87% -2.96% 12M
|
Health Care and Social Assistan...
|
| O: 1.65%
H: 0.0%
C: 0.0%
bt-600 fda treatment clearance application therapeutics
FDA Grants Priority Review for Supplemental Biologics License Application (sBLA) of PADCEV® (enfortumab vedotin-ejfv) with KEYTRUDA® (pembrolizumab) for First-Line Treatment of Advanced Bladder Cancer
Published: 2023-11-30 (Crawled : 22:00) - prnewswire.com
PFE | $28.91 -5.12% 0.24% 97M
|
Health Technology
|
| O: -4.15%
H: 0.0%
C: 0.0%
padcev fda license review bladder cancer treatment application grants
ObsEva Announces Application for a Moratorium to Facilitate Pivotal Deals
Published: 2023-11-30 (Crawled : 06:00) - globenewswire.com
OBSVF | $ 0%
|
n/a
| Email alert
Add to watchlist
OBSV | $0.1018 -15.52% -18.95% 8.2M
|
Health Technology
| Email alert
Add to watchlist
application
Harrow Completes Transfer of the TRIESENCE® New Drug Application
Published: 2023-11-29 (Crawled : 21:00) - biospace.com/
HROW | $9.31 0.87% 0.97% 390K
|
Health Technology
|
| O: 1.33%
H: 3.95%
C: -1.43%
triesence drug transfer application
PureTech Founded Entity Karuna Therapeutics Announces U.S. Food and Drug Administration Accepts New Drug Application for KarXT for the Treatment of Schizophrenia
Published: 2023-11-29 (Crawled : 20:00) - biospace.com/
KRTX | $196.53 2.78% 1.77% 230K
|
Health Technology
|
| O: 0.74%
H: 3.66%
C: 0.99%
drug food treatment schizophrenia application therapeutics
Karuna Therapeutics Announces U.S. Food and Drug Administration Accepts New Drug Application for KarXT for the Treatment of Schizophrenia
Published: 2023-11-29 (Crawled : 15:30) - biospace.com/
KRTX | $196.53 2.78% 1.77% 230K
|
Health Technology
|
| O: 0.74%
H: 3.66%
C: 0.99%
drug food treatment schizophrenia application therapeutics
uniQure Announces FDA Clearance of Investigational New Drug Application for AMT-191 Gene Therapy for Fabry DiseasePatient enrollment expected to begin in first half of 2024
Published: 2023-11-29 (Crawled : 14:30) - biospace.com/
QURE | $7.14 5.31% 4.84% 740K
|
Health Technology
|
| O: 3.25%
H: 4.58%
C: -2.58%
amt-191 fda drug expected clearance application therapy
FDA Accepts Arcutis’ Supplemental New Drug Application for Roflumilast Cream 0.15% for the Treatment of Atopic Dermatitis in Adults and Children Down to Age 6
Published: 2023-11-29 (Crawled : 13:00) - globenewswire.com
ARQT M | $1.99 8.15% 0.0% 2.9M
|
Health Technology
|
| O: 3.43%
H: 0.0%
C: 0.0%
fda drug children dermatitis treatment application
uniQure Announces FDA Clearance of Investigational New Drug Application for AMT-191 Gene Therapy for Fabry Disease
Published: 2023-11-29 (Crawled : 12:00) - globenewswire.com
QURE | $7.14 5.31% 4.84% 740K
|
Health Technology
|
| O: 3.25%
H: 4.58%
C: -2.58%
amt-191 fda drug disease clearance application therapy
Applied DNA Announces Receipt of Linea(TM) DNA Follow-On Order for Cancer Diagnostic Application
Published: 2023-11-28 (Crawled : 15:00) - biospace.com/
APDN | $0.949 7.84% 7.37% 61K
|
Commercial Services
|
| O: 2.27%
H: 4.81%
C: -0.22%
diagnostic cancer dna order application
Aldeyra Therapeutics Receives Complete Response Letter from the U.S. Food and Drug Administration for the Reproxalap New Drug Application for the Treatment of Dry Eye Disease
Published: 2023-11-27 (Crawled : 23:00) - biospace.com/
ALDX | $2.86 3.25% 0.35% 910K
|
Health Technology
| Email alert
Add to watchlist
reproxalap drug disease food treatment eye application therapeutics response
Mullen Automotive Provides Update on US Customs and Border Protection Application for Class 1 EV Cargo Vans
Published: 2023-11-27 (Crawled : 13:30) - globenewswire.com
MULN | $0.1635 7.57% 6.4% 61M
|
Information
| Email alert
Add to watchlist
update application automotive
Gracell Biotechnologies Announces FDA Clearance of IND Application for Phase 1/2 Clinical Trial of FasTCAR-T GC012F for the Treatment of Refractory Systemic Lupus Erythematosus
Published: 2023-11-27 (Crawled : 13:00) - globenewswire.com
GRCL | $5.29 8.62% 7.24% 260K
|
Manufacturing
| Email alert
Add to watchlist
gc012 fda biotechnologies lupus treatment clearance application trial
Abeona Therapeutics Announces FDA Accepts and Grants Priority Review for Pz-cel Biologics License Application (BLA)
Published: 2023-11-27 (Crawled : 12:30) - globenewswire.com
ABEO | $4.66 -2.92% 0.86% 150K
|
Health Technology
|
| O: 10.71%
H: 16.96%
C: 4.57%
fda license review application grants therapeutics
Prairie Operating Co. Submits Weld County Oil and Gas Location Assessment and Begins Permit Application Process for Second Oil and Gas Development Plan
Published: 2023-11-27 (Crawled : 12:30) - globenewswire.com
CRKR | $0.515 2.49% -58.72% 110K
|
Mining, Quarrying, and Oil and ...
| Email alert
Add to watchlist
CRKRD | $16.09 2.16% -6.25% 39K
|
n/a
| Email alert
Add to watchlist
gas application oil
Autolus Therapeutics Submits Biologics License Application to U.S. Food and Drug Administration for obecabtagene autoleucel (obe-cel) for Patients with Relapsed/refractory (r/r) Adult B-Cell Acute Lymphoblastic Leukemia (ALL)
Published: 2023-11-27 (Crawled : 12:00) - globenewswire.com
AUTL | $4.19 -2.1% 4.77% 510K
|
Health Technology
|
| O: 1.87%
H: 4.09%
C: 3.02%
drug license food application leukemia therapeutics
Krystal Biotech Announces EMA Validation of Marketing Authorization Application for VYJUVEK for the Treatment of Dystrophic Epidermolysis Bullosa
Published: 2023-11-27 (Crawled : 12:00) - globenewswire.com
KRYS | $106.26 1.95% -2.43% 190K
|
Health Technology
|
| O: 2.51%
H: 0.05%
C: -3.94%
vyjuvek biotech authorization treatment ema application
Application for quotation of securities
Published: 2023-11-27 (Crawled : 07:00) - clinuvel.com
CLVLY | $11.8 0.3% 7.03% 2.5K
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
CLVLF | $10.05 35.85% 860
|
Health Technology
| Email alert
Add to watchlist
application
Gainers vs Losers
| 77% | 23% |
Top 10 Gainers
ID 4 | $0.077 -9.41% 25.97% 420K
|
Finance
BKKT 4 | $1.88 25.33% 14.89% 4.8M
|
PHGE | $0.258 -0.39% 8.49% 360K
|
Health Technology
MGLD | $1.03 7.77% 14K
|
Manufacturing
CZOO | $0.4316 -6.52% 6.7% 65K
|
SATX | $0.4226 -1.72% 6.48% 29K
|
n/a
CCJ | $45.4 -1.13% 4.6% 3.9M
|
Non-Energy Minerals
AUMN | $0.562 0.34% 4.5% 360K
|
Non-Energy Minerals
ERJ | $18.69 6.86% 4.33% 2.9M
|
Electronic Technology
JBL | $116.91 1.38% 4.3% 2M
|
Electronic Technology
Your saved searches
Save your searches and get alerts when important news are released.